The downregulation of TFRC leads to reduced iron transport [37], and the low expression of ACSL4 impairs the catalysis of the substrates necessary for the formation of lipid hydroperoxides [38], thereby reducing ferroptosis-mediated cell death in tumor cells. Here, ACSL4 is linked to neoplasm.